Using Deep Learning and Radiomics to Diagnose Benign and Malignant Breast Lesions Based on Ultrasound
- Conditions
- Breast Diseases
- Registration Number
- NCT06069921
- Lead Sponsor
- Ma Zhe
- Brief Summary
This retrospective study aimed to create a prediction model using deep learning and radiomics features extracted from intratumoral and peritumoral regions of breast lesions in ultrasound images, to diagnose benign and malignant breast lesions with BI-RADS 4 classification.
Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 400
- female patients with US-visible solid breast masses who underwent biopsy and/or surgical resection, and were classified as having BI-RADS 4 lesions in medical US reports.
- preoperative endocrine therapy, chemotherapy, or radiotherapy, preoperative invasive breast operation, insufficient image quality, and no pathological results.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method radiomcis prediction model and the model evaluation Immediately evaluated after the radiomcis prediction model was built three radiomics models were established using the support vector machines algorithm based on features extracted from the intratumoral, peritumoral, and combined regions of the breast lesions.The models were evaluated using various metrics, including AUC, accuracy, sensitivity, specificity, PPV, and NPV
- Secondary Outcome Measures
Name Time Method deep learning prediction model and the model evaluation Immediately evaluated after the deep learning prediction model was built three deep learning models were established using the support vector machines algorithm based on features extracted from the intratumoral, peritumoral, and combined regions of the breast lesions.The models were evaluated using various metrics, including AUC, accuracy, sensitivity, specificity, PPV, and NPV
Trial Locations
- Locations (1)
QianfoshanH
🇨🇳Jinan, Shandong, China